This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Jump to section
Related Articles
Cited By...
- 18F-FDG PET/CT for Monitoring of Ipilimumab Therapy in Patients with Metastatic Melanoma
- Evaluation of Dual-Timepoint 18F-FDG PET/CT Imaging for Lymph Node Staging in Vulvar Cancer
- Metabolic PET/CT-Guided Lung Lesion Biopsies: Impact on Diagnostic Accuracy and Rate of Sampling Error
- Splenic Metabolic Activity Predicts Risk of Future Cardiovascular Events: Demonstration of a Cardiosplenic Axis in Humans
- 18FDG-PET-CT: An Imaging Biomarker of High-Risk Carotid Plaques. Correlation to Symptoms and Microembolic Signals
- Measurement of Arterial Activity on Routine FDG PET/CT Images Improves Prediction of Risk of Future CV Events
- Intensification of Statin Therapy Results in a Rapid Reduction in Atherosclerotic Inflammation: Results of a Multicenter Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography Feasibility Study
- Evaluation of 4'-[Methyl-11C]Thiothymidine in a Rodent Tumor and Inflammation Model
- Imaging Inflammatory Changes in Atherosclerosis: Multimodal Imaging Hitting Stride
- The use of positron emission tomography/CT in the diagnosis of tuberculosis-associated uveitis
- Positron Emission Tomography Measurement of Periodontal 18F-Fluorodeoxyglucose Uptake Is Associated With Histologically Determined Carotid Plaque Inflammation
- Measuring Tumor Cell Proliferation with 18F-FLT PET During Radiotherapy of Esophageal Squamous Cell Carcinoma: A Pilot Clinical Study
- A New PET Scanner with Semiconductor Detectors Enables Better Identification of Intratumoral Inhomogeneity
- [18F]Fluorothymidine Positron Emission Tomography before and 7 Days after Gefitinib Treatment Predicts Response in Patients with Advanced Adenocarcinoma of the Lung
- Imaging Bone and Soft Tissue Tumors with the Proliferation Marker [18F]Fluorodeoxythymidine
- Early Response Assessment Using 3'-Deoxy-3'-[18F]Fluorothymidine-Positron Emission Tomography in High-Grade Non-Hodgkin's Lymphoma
- PET-Based Treatment Planning in Radiotherapy: A New Standard?
- Molecular Imaging of Proliferation in Malignant Lymphoma.
- Evaluation of D-Isomers of O-11C-Methyl Tyrosine and O-18F-Fluoromethyl Tyrosine as Tumor-Imaging Agents in Tumor-Bearing Mice: Comparison with L- and D-11C-Methionine
- PET Evaluation of Lung Cancer
- Association of Vascular 18F-FDG Uptake with Vascular Calcification
- Biologic Correlates of Intratumoral Heterogeneity in 18F-FDG Distribution with Regional Expression of Glucose Transporters and Hexokinase-II in Experimental Tumor
- Molecular and Metabolic Imaging of Atherosclerosis
- Assessment of Disease Activity in Rheumatoid Arthritis with 18F-FDG PET
- Selectivity of 18F-FLT and 18F-FDG for Differentiating Tumor from Inflammation in a Rodent Model
- Analysis of the Regional Uptake of Radiolabeled Deoxyglucose Analogs in Human Tumor Xenografts
- Imaging Proliferation in Lung Tumors with PET: 18F-FLT Versus 18F-FDG
- 3'-[18F]Fluoro-3'-Deoxythymidine ([18F]-FLT) as Positron Emission Tomography Tracer for Imaging Proliferation in a Murine B-Cell Lymphoma Model and in the Human Disease